The selective IKK inhibitor, NEMO Binding Domain (NBD) peptide effectively blocks constitutive NF-κB activity and induces apoptosis in ABC-DLBCL cells in vitro. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.